Benzinga | Dec 3, 2021 05:29AM EST

UBS Downgrades DocuSign to Neutral, Lowers Price Target to $170

UBS analyst Karl Keirstead downgrades DocuSign (NASDAQ:DOCU) from Buy to Neutral and lowers the price target from $350 to $170.